Viewing Study NCT02179567


Ignite Creation Date: 2025-12-25 @ 12:56 AM
Ignite Modification Date: 2026-03-02 @ 4:05 AM
Study NCT ID: NCT02179567
Status: TERMINATED
Last Update Posted: 2015-09-28
First Post: 2014-06-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Docetaxel Plus Bevacizumab for Elderly Patients With Stage IV NSCLC
Sponsor: Hellenic Oncology Research Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module